Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | Physostigmine | HCID 5983 | — |
| Reactant | 1,2,3,4-Tetrahydroisoquinoline | HCID 7046 | — |
| Reactant | 1,1'-Carbonyldiimidazole | HCID 68263 | — |
| Reactant | Eseroline | HCID 119198 | — |
| Reactant | Potassium tert-butoxide | HCID 23665647 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | Quilostigmine | HCID 132228 | — |
Reaction Steps
To a solution of physostigmine (2.75 g) in dry THF (28 mL) at 25° C. under a nitrogen atmosphere was treated with KOtBu (1.28 g), added over 0.25 hour, aged 0.5 hour at 25° C., then treated with glacial HOAc (0.6 mL, 1 equiv., pH=10) to give a mixture containing physostigmine (II) and eseroline (III) in a 1/99 HPLC ratio. Addition of 1,1'-carbonyldiimidazole (1.7 g, 1.05 equiv) added in 1.0 and 0.05 equiv. portions at 1.25 hour intervals at -20° C. gave after 1.0 hour following each addition the following HPLC ratio of imidazolecarbonyl intermediate (V) and eseroline: 97/3 and 99/1. Addition of glacial HOAc (3.4 mL, 6 equiv., pH=5) followed by 1,2,3,4-tetrahydroisoquinoline (1.5 g, 1.1 equiv., added over 0.5 hour at 15° C.) gave after 4 hours at 25° C. a mixture containing (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl 3,4-dihyclro-2(1H)-isoquinolinecarboxylate and eseroline in a 98/2 HPLC ratio.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05498726 |
|---|
| Source dataset | uspto-grants-1996_03 |
|---|
| ORD ID | ord-12c3468d03aa422abcf25d26e5eddb6a |
|---|
| Source note | uspto-grants-1996_03 |
|---|